Bellevue Healthcare (BBH) Competitors

Bellevue Healthcare (LON:BBH) and JPMorgan Emerging Markets (LON:JMG) are both small-cap financial services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings, community ranking and profitability.

Is BBH or JMG a better dividend stock?

Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 5.1%. JPMorgan Emerging Markets pays an annual dividend of GBX 2 per share and has a dividend yield of 1.8%. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. JPMorgan Emerging Markets pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bellevue Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.

Do insiders & institutionals believe in BBH or JMG?

40.6% of Bellevue Healthcare shares are owned by institutional investors. Comparatively, 48.5% of JPMorgan Emerging Markets shares are owned by institutional investors. 0.1% of Bellevue Healthcare shares are owned by company insiders. Comparatively, 1.8% of JPMorgan Emerging Markets shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Does the media favor BBH or JMG?

In the previous week, JPMorgan Emerging Markets had 1 more articles in the media than Bellevue Healthcare. MarketBeat recorded 1 mentions for JPMorgan Emerging Markets and 0 mentions for Bellevue Healthcare. JPMorgan Emerging Markets' average media sentiment score of 1.05 beat Bellevue Healthcare's score of 0.00 indicating that JPMorgan Emerging Markets is being referred to more favorably in the news media.

Company	Overall Sentiment
Bellevue Healthcare	Neutral
JPMorgan Emerging Markets	Positive

Is BBH or JMG more profitable?

Bellevue Healthcare has a net margin of 169.10% compared to JPMorgan Emerging Markets' net margin of 82.19%. JPMorgan Emerging Markets' return on equity of 6.30% beat Bellevue Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bellevue Healthcare	169.10%	-4.48%	N/A
JPMorgan Emerging Markets	82.19%	6.30%	1.55%

Which has stronger earnings & valuation, BBH or JMG?

JPMorgan Emerging Markets has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than JPMorgan Emerging Markets, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bellevue Healthcare	-£9.60M	-30.42	-£16.23M	-£6.57	-18.02
JPMorgan Emerging Markets	£97.45M	11.88	£80.10M	£7.55	14.48

Does the MarketBeat Community prefer BBH or JMG?

Bellevue Healthcare received 33 more outperform votes than JPMorgan Emerging Markets when rated by MarketBeat users. However, 75.73% of users gave JPMorgan Emerging Markets an outperform vote while only 68.52% of users gave Bellevue Healthcare an outperform vote.

Company	Underperform	Outperform
Bellevue Healthcare	Outperform Votes 111 68.52%	Underperform Votes 51 31.48%
JPMorgan Emerging Markets	Outperform Votes 78 75.73%	Underperform Votes 25 24.27%

Summary

JPMorgan Emerging Markets beats Bellevue Healthcare on 12 of the 16 factors compared between the two stocks.